Scholarlink

<p>The conceptual framework of the ‘gut-brain axis’ proposes that an imbalance in the gut microbiota plays a contributory role in the etiology of Parkinson’s disease (PD). However, the specific molecular mechanisms, particularly those involving ferroptosis, remain largely unknown. We adopted a robust two-sample Mendelian randomization (MR) strategy, analyzing extensive summary-level GWAS data to unravel the causal connections tying the gut microbiota and ferroptosis-associated proteins to the risk of PD. Our analysis pinpointed 22 distinct gut microbial taxa and five proteins involved in ferroptosis that are genetically predicted to influence PD susceptibility. Notably, the family <i>Fusobacteriaceae</i> was identified as a robust risk factor. Further mediation analysis suggested that the ferroptosis-related protein carbonic anhydrase 9 (CA9) mediates the genetically predicted effect of <i>Fusobacteriaceae</i> on PD. Specifically, an elevated genetic predisposition to <i>Fusobacteriaceae</i> is associated with a downregulation of plasma CA9, a molecular shift that is genetically predicted to heighten the risk of developing PD. The calculated mediation proportion was 11.7%, and the robustness of this result was upheld by comprehensive sensitivity assessments. This study provides novel genetic evidence supporting a potential “gut microbiota–ferroptosis–PD” axis. We propose that <i>Fusobacteriaceae</i> may aggravate PD progression by downregulating CA9, thereby compromising CA9-dependent anti-ferroptotic defense mechanisms. Collectively, our results provide fresh perspectives on the molecular mechanisms underpinning the gut-brain axis, highlighting promising avenues for therapeutic intervention in PD.&#xa0;</p> Graphical Abstract <p>The proposed Fusobacteriaceae-CA9-Ferroptosis axis in Parkinson’s disease pathogenesis. A genetically predicted overabundance of Fusobacteriaceae compromises intestinal barrier integrity, facilitating the systemic translocation of lipopolysaccharides (LPS). Upon crossing the blood-brain barrier (BBB), circulating LPS triggers microglial activation and the sustained release of pro-inflammatory cytokines (e.g., TNF-α, IL-1β). This chronic neuroinflammatory microenvironment represses the transcription and expression of the pH-regulating protein carbonic anhydrase 9 (CA9) in dopaminergic neurons. The subsequent CA9 downregulation induces severe intracellular acidification, which dualistically expands the labile iron pool (LIP) via ferritin degradation and cripples the antioxidant defense system by depleting glutathione (GSH) and inactivating GPX4. Ultimately, the confluence of elevated ferrous iron (Fe²⁺) and an acidic milieu aggressively accelerates the Fenton reaction, driving massive lipid peroxidation of polyunsaturated fatty acids (PUFAs) and culminating in neuronal ferroptosis</p> <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Unveiling the Gut-Brain Axis: Fusobacteriaceae Promotes Parkinson’s Disease Development via CA9 Suppression-Induced Ferroptosis

  • 期刊论文

  • 发表日期：

    2026年4月25日

查看全文
  • Ren Zihan,
  • Li Pengfei,
  • Cao Jingsi

摘要

The conceptual framework of the ‘gut-brain axis’ proposes that an imbalance in the gut microbiota plays a contributory role in the etiology of Parkinson’s disease (PD). However, the specific molecular mechanisms, particularly those involving ferroptosis, remain largely unknown. We adopted a robust two-sample Mendelian randomization (MR) strategy, analyzing extensive summary-level GWAS data to unravel the causal connections tying the gut microbiota and ferroptosis-associated proteins to the risk of PD. Our analysis pinpointed 22 distinct gut microbial taxa and five proteins involved in ferroptosis that are genetically predicted to influence PD susceptibility. Notably, the family Fusobacteriaceae was identified as a robust risk factor. Further mediation analysis suggested that the ferroptosis-related protein carbonic anhydrase 9 (CA9) mediates the genetically predicted effect of Fusobacteriaceae on PD. Specifically, an elevated genetic predisposition to Fusobacteriaceae is associated with a downregulation of plasma CA9, a molecular shift that is genetically predicted to heighten the risk of developing PD. The calculated mediation proportion was 11.7%, and the robustness of this result was upheld by comprehensive sensitivity assessments. This study provides novel genetic evidence supporting a potential “gut microbiota–ferroptosis–PD” axis. We propose that Fusobacteriaceae may aggravate PD progression by downregulating CA9, thereby compromising CA9-dependent anti-ferroptotic defense mechanisms. Collectively, our results provide fresh perspectives on the molecular mechanisms underpinning the gut-brain axis, highlighting promising avenues for therapeutic intervention in PD. 

Graphical Abstract

The proposed Fusobacteriaceae-CA9-Ferroptosis axis in Parkinson’s disease pathogenesis. A genetically predicted overabundance of Fusobacteriaceae compromises intestinal barrier integrity, facilitating the systemic translocation of lipopolysaccharides (LPS). Upon crossing the blood-brain barrier (BBB), circulating LPS triggers microglial activation and the sustained release of pro-inflammatory cytokines (e.g., TNF-α, IL-1β). This chronic neuroinflammatory microenvironment represses the transcription and expression of the pH-regulating protein carbonic anhydrase 9 (CA9) in dopaminergic neurons. The subsequent CA9 downregulation induces severe intracellular acidification, which dualistically expands the labile iron pool (LIP) via ferritin degradation and cripples the antioxidant defense system by depleting glutathione (GSH) and inactivating GPX4. Ultimately, the confluence of elevated ferrous iron (Fe²⁺) and an acidic milieu aggressively accelerates the Fenton reaction, driving massive lipid peroxidation of polyunsaturated fatty acids (PUFAs) and culminating in neuronal ferroptosis